Defense-to-Offense: PhRMA Readies to Protect Government Markets
This article was originally published in RPM Report
Executive Summary
White House budget targeting biopharma with new cuts hits just as the Pharmaceutical Research & Manufacturers of America’s annual meeting gets under way.